This clinical-stage biotech develops therapies targeting hematologic disorders, with a pipeline centered on red blood cell biology.
Disc Medicine develops therapies for rare blood disorders, leveraging clinical-stage biotech expertise in red blood cell ...
Researchers at UChicago have developed a nanoparticle system that can effectively deliver mRNA to insulin-producing cells, protecting them from the body’s autoimmune response ...
They call it a “world model”, an essential tool to help AI systems make sense of the complex, unpredictable physical spaces ...
In a 2023 paper on hypoxia and glucose metabolism, our lab showed how organisms rewire their metabolism to adapt to low ...
As Uganda rolls out mandatory nationwide screening of newborns for sickle cell disease this month, a gene therapy celebrated in the United States and Europe remains financially out of reach for most ...
People living at high altitude have long been observed to develop diabetes less often than those at sea level. Scientists now say they have identified a biological explanation for the trend.
Princeton, New Jersey Wednesday, February 25, 2026, 12:00 Hrs [IST] ...
L iving at high altitude appears to protect against diabetes, and scientists have finally discovered the reason. When oxygen levels drop, red blood cells switch into a new metabol ...
Hypoxic conditions trigger red blood cells to absorb and utilize more glucose, reducing blood sugar and offering a potential therapy to control diabetes.
What we breathe out becomes fuel for forests. But inside our own bodies, CO₂ has a secret life. It sparks chemical reactions, shapes metabolism, and may even act as a signaling molecule—and a new tool ...
People in prisons in Louisiana and across the nation say they're not receiving proper medical care. Why are these cases so common?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results